The FDA’s Woodcock said that monoclonal antibodies are “fairly sensitive” to changes in the virus and that the companies making them and the government are testing the treatments against various strains.
The mistake is highly unusual because Regeneron’s drug, a cocktail of two monoclonal antibodies, is given by infusion, rather than as a shot.
The FDA grants emergency use authorization for Eli Lilly’s monoclonal antibody therapy.
We’ve got Regeneron’s antibody cocktail, monoclonal antibodies, and other sophisticated treatments, so patients are recovering faster.
The drug consists of three different monoclonal antibodies, human-made antibodies designed to mimic those produced naturally during an immune response.